The DOI matches its Crossref record; 341 of the 341 references it cites were found in a registry or an index.
Sp1 and the ‘hallmarks of cancer’
Open accessAbstract
For many years, transcription factor Sp1 was viewed as a basal transcription factor and relegated to a role in the regulation of so‐called housekeeping genes. Identification of Sp1's role in recruiting the general transcription machinery in the absence of a TATA box increased its importance in gene regulation, particularly in light of recent estimates that the majority of mammalian genes lack a TATA box. In this review, we briefly consider the history of Sp1, the founding member of the Sp family of transcription factors. We review the evidence suggesting that Sp1 is highly regulated by post‐translational modifications that positively and negatively affect the activity of Sp1 on a wide array of genes. Sp1 is over‐expressed in many cancers and is associated with poor prognosis. Targeting Sp1 in cancer treatment has been suggested; however, our review of the literature on the role of Sp1 in the regulation of genes that contribute to the ‘hallmarks of cancer’ illustrates the extreme complexity of Sp1 functions. Sp1 both activates and suppresses the expression of a number of essential oncogenes and tumor suppressors, as well as genes involved in essential cellular functions, including proliferation, differentiation, the DNA damage response, apoptosis, senescence and angiogenesis. Sp1 is also implicated in inflammation and genomic instability, as well as epigenetic silencing. Given the apparently opposing effects of Sp1, a more complete understanding of the function of Sp1 in cancer is required to validate its potential as a therapeutic target.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Ets-1 Positively Regulates Fas Ligand Transcription via Cooperative Interactions with Sp1
Kavurma, M. M., Bobryshev, Y. V., & Khachigian, L. M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200463200 · Cited by 68
RetractedHallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
CpG Islands in vertebrate genomes
Gardiner-Garden, M., & Frommer, M. (1987) · Journal of Molecular Biology · doi:10.1016/0022-2836(87)90689-9 · Cited by 3,353
p21 in cancer: Intricate networks and multiple activities
Abbas, T., & Dutta, A. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2657 · Cited by 2,712
A gene hypermethylation profile of human cancer.
Esteller, M., Corn, P. G., Baylin, S. B., & Herman, J. G. (2001) · PubMed · Cited by 2,032
A quantitative atlas of mitotic phosphorylation
Dephoure, N., Zhou, C., Villén, J., Beausoleil, S. A., Bakalarski, C. E., Elledge, S. J., & Gygi, S. P. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0805139105 · Cited by 1,608
Beausoleil, S. A., Villén, J., Gerber, S. A., Rush, J., & Gygi, S. P. (2006) · Nature Biotechnology · doi:10.1038/nbt1240 · Cited by 1,577
Quantitative Phosphoproteomics Reveals Widespread Full Phosphorylation Site Occupancy During Mitosis
Olsen, J. V., Vermeulen, M., Santamaria, A., Kumar, C., Miller, M. L., Jensen, L. J., Gnad, F., Cox, J., Jensen, T. S., Nigg, E. A., et al. (2010) · Science Signaling · doi:10.1126/scisignal.2000475 · Cited by 1,479
Tischer, E., Mitchell, R., Hartman, T., Silva, M., Gospodarowicz, D., Fiddes, J. C., & Abraham, J. A. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)99049-6 · Cited by 1,476
DNA secondary structures: stability and function of G-quadruplex structures
Bochman, M. L., Paeschke, K., & Zakian, V. A. (2012) · Nature Reviews Genetics · doi:10.1038/nrg3296 · Cited by 1,446
Dynan, W. S., & Tjian, R. (1983) · Cell · doi:10.1016/0092-8674(83)90210-6 · Cited by 1,445
Courey, A. J., & Tjian, R. (1988) · Cell · doi:10.1016/0092-8674(88)90144-4 · Cited by 1,354
Hart, G. W., Slawson, C., Ramirez-Correa, G., & Lagerlof, O. (2011) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-060608-102511 · Cited by 1,317
Bond, G. L., Hu, W., Bond, E. E., Robins, H., Lutzker, S. G., Arva, N. C., Bargonetti, J., Bartel, F., Taubert, H., Wuerl, P., et al. (2004) · Cell · doi:10.1016/j.cell.2004.11.022 · Cited by 1,265
p53-dependent and independent expression of p21 during cell growth, differentiation, and DNA damage.
Macleod, K. F., Sherry, N., Hannon, G., Beach, D., Tokino, T., Kinzler, K., Vogelstein, B., & Jacks, T. (1995) · Genes & Development · doi:10.1101/gad.9.8.935 · Cited by 1,119
The insulin and insulin-like growth factor receptor family in neoplasia: an update
Pollak, M. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3215 · Cited by 1,116
Cawley, S., Bekiranov, S., Ng, H. H., Kapranov, P., Sekinger, E. A., Kampa, D., Piccolboni, A., Sementchenko, V., Cheng, J., Williams, A. J., et al. (2004) · Cell · doi:10.1016/s0092-8674(04)00127-8 · Cited by 1,095
Sp1 and krüppel‐like factor family of transcription factors in cell growth regulation and cancer
Black, A. R., Black, J. D., & Azizkhan‐Clifford, J. (2001) · Journal of Cellular Physiology · doi:10.1002/jcp.1111 · Cited by 1,049
Self-citationPromoter-specific activation of RNA polymerase II transcription by Sp1
Kadonaga, J. T., Jones, K. A., & Tjian, R. (1986) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(86)90226-4 · Cited by 1,012
Sp1- and Krüppel-like transcription factors.
Kaczynski, J., Cook, T. A., & Urrutia, R. A. (2003) · Genome biology · doi:10.1186/gb-2003-4-2-206 · Cited by 983
Jackson, S. P., & Tjian, R. (1988) · Cell · doi:10.1016/0092-8674(88)90015-3 · Cited by 879
Cellular senescence and tumor suppressor gene p16
Rayess, H., Wang, M. B., & Srivatsan, E. S. (2012) · International Journal of Cancer · doi:10.1002/ijc.27316 · Cited by 825
Shibuya, M. (2013) · Journal of Biochemistry · doi:10.1093/jb/mvs136 · Cited by 792
Dynan, W. S., & Tjian, R. (1983) · Cell · doi:10.1016/0092-8674(83)90053-3 · Cited by 732
Sp1 and TAFII130 Transcriptional Activity Disrupted in Early Huntington's Disease
Dunah, A. W., Jeong, H., Griffin, A., Kim, Y.-M., Standaert, D. G., Hersch, S. M., Mouradian, M. M., Young, A. B., Tanese, N., & Krainc, D. (2002) · Science · doi:10.1126/science.1072613 · Cited by 708
Spl elements protect a CpG island from de novo methylation
Brandeis, M., Frank, D., Keshet, I., Siegfried, Z., Mendelsohn, M., Names, A., Temper, V., Razin, A., & Cedar, H. (1994) · Nature · doi:10.1038/371435a0 · Cited by 706
Sp1-mediated transcriptional activation is repressed by Sp3.
Hagen, G., Müller, S., Beato, M., & Suske, G. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06695.x · Cited by 685
GC box binding induces phosphorylation of Sp1 by a DNA-dependent protein kinase
Jackson, S. P., MacDonald, J. J., Lees-Miller, S., & Tjian, R. (1990) · Cell · doi:10.1016/0092-8674(90)90296-q · Cited by 669
Hoey, T., Weinzierl, R. O. J., Gill, G., Chen, J.-L., Dynlacht, B. D., & Tjian, R. (1993) · Cell · doi:10.1016/0092-8674(93)90664-c · Cited by 572
Epidermal growth factor receptor in relation to tumor development: EGFR gene and cancer
Mitsudomi, T., & Yatabe, Y. (2010) · The FEBS Journal · doi:10.1111/j.1742-4658.2009.07448.x · Cited by 559
Marin, M., Karis, A., Visser, P., Grosveld, F., & Philipsen, S. (1997) · Cell · doi:10.1016/s0092-8674(00)80243-3 · Cited by 542
Gill, G., Pascal, E., Tseng, Z. H., & Tjian, R. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.1.192 · Cited by 531
Kingsley, C., & Winoto, A. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.10.4251 · Cited by 521
Romagosa, C., Simonetti, S., López-Vicente, L., Mazo, A., Lleonart, M. E., Castellvi, J., & Ramon y Cajal, S. (2011) · Oncogene · doi:10.1038/onc.2010.614 · Cited by 509
Functional selectivity of recombinant mammalian SWI/SNF subunits
Kadam, S., McAlpine, G. S., Phelan, M. L., Kingston, R. E., Jones, K. A., & Emerson, B. M. (2000) · Genes & Development · doi:10.1101/gad.828000 · Cited by 497
Kyo, S. (2000) · Nucleic Acids Research · doi:10.1093/nar/28.3.669 · Cited by 494
高倉, 正. (2002) · Medical Entomology and Zoology · Cited by 475
Displacement of sequence-specific transcription factors from mitotic chromatin
Martínez-Balbás, M. A., Dey, A., Rabindran, S. K., Ozato, K., & Wu, C. (1995) · Cell · doi:10.1016/0092-8674(95)90231-7 · Cited by 454
Rigbolt, K. T. G., Prokhorova, T. A., Akimov, V., Henningsen, J., Johansen, P. T., Kratchmarova, I., Kassem, M., Mann, M., Olsen, J. V., & Blagoev, B. (2011) · Science Signaling · doi:10.1126/scisignal.2001570 · Cited by 451
Regulation of the activity of Sp1-related transcription factors
Bouwman, P., & Philipsen, S. (2002) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(02)00221-6 · Cited by 448
The Type 1 Insulin-Like Growth Factor Receptor Pathway
Chitnis, M. M., Yuen, J. S. P., Protheroe, A. S., Pollak, M., & Macaulay, V. M. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-4879 · Cited by 445
PAGES, G., & POUYSSEGUR, J. (2005) · Cardiovascular Research · doi:10.1016/j.cardiores.2004.09.032 · Cited by 443
Reduced O Glycosylation of Sp1 Is Associated with Increased Proteasome Susceptibility
Han, I., & Kudlow, J. E. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.5.2550 · Cited by 437
Multiple roles of the cell cycle inhibitor p21CDKN1A in the DNA damage response
Cazzalini, O., Scovassi, A. I., Savio, M., Stivala, L. A., & Prosperi, E. (2010) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2010.01.009 · Cited by 433
Myc represses the p21 (WAF1/CIP1) promoter and interacts with Sp1/Sp3
Gartel, A. L., Ye, X., Goufman, E., Shianov, P., Hay, N., Najmabadi, F., & Tyner, A. L. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.081074898 · Cited by 417
Histone Deacetylase 1 Can Repress Transcription by Binding to Sp1
Doetzlhofer, A., Rotheneder, H., Lagger, G., Koranda, M., Kurtev, V., Brosch, G., Wintersberger, E., & Seiser, C. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.8.5504 · Cited by 398
Smad2, Smad3 and Smad4 cooperate with Sp1 to induce p15Ink4B transcription in response to TGF-β
Feng, X.-H., Lin, X., & Derynck, R. (2000) · The EMBO Journal · doi:10.1093/emboj/19.19.5178 · Cited by 397
Caldwell, S. A., Jackson, S. R., Shahriari, K. S., Lynch, T. P., Sethi, G., Walker, S., Vosseller, K., & Reginato, M. J. (2010) · Oncogene · doi:10.1038/onc.2010.41 · Cited by 396
Cloning of an Intrinsic Human TFIID Subunit That Interacts with Multiple Transcriptional Activators
Chiang, C.-M., & Roeder, R. G. (1995) · Science · doi:10.1126/science.7824954 · Cited by 389
Chen, J.-L., Attardi, L. D., Verrijzer, C. P., Yokomori, K., & Tjian, R. (1994) · Cell · doi:10.1016/0092-8674(94)90403-0 · Cited by 370
Distinct Regions of Sp1 Modulate DNA Binding and Transcriptional Activation
Kadonaga, J. T., Courey, A. J., Ladika, J., & Tjian, R. (1988) · Science · doi:10.1126/science.3059495 · Cited by 362
Senescent cells harbour features of the cancer epigenome
Cruickshanks, H. A., McBryan, T., Nelson, D. M., VanderKraats, N. D., Shah, P. P., van Tuyn, J., Singh Rai, T., Brock, C., Donahue, G., Dunican, D. S., et al. (2013) · Nature Cell Biology · doi:10.1038/ncb2879 · Cited by 358
DNA methylation represses transcription in vivo
Siegfried, Z., Eden, S., Mendelsohn, M., Feng, X., Tsuberi, B.-Z., & Cedar, H. (1999) · Nature Genetics · doi:10.1038/9727 · Cited by 354
Moustakas, A., & Kardassis, D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.12.6733 · Cited by 354
Owen, G. I., Richer, J. K., Tung, L., Takimoto, G., & Horwitz, K. B. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.17.10696 · Cited by 349
DNA looping between sites for transcriptional activation: self-association of DNA-bound Sp1.
Su, W., Jackson, S., Tjian, R., & Echols, H. (1991) · Genes & Development · doi:10.1101/gad.5.5.820 · Cited by 347
HIF-1α Induces Genetic Instability by Transcriptionally Downregulating MutSα Expression
Koshiji, M., To, K. K.-W., Hammer, S., Kumamoto, K., Harris, A. L., Modrich, P., & Huang, L. E. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.02.015 · Cited by 346
Mukhopadhyay, D., Knebelmann, B., Cohen, H. T., Ananth, S., & Sukhatme, V. P. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.9.5629 · Cited by 341
Interaction of Huntington Disease Protein with Transcriptional Activator Sp1
Li, S.-H., Cheng, A. L., Zhou, H., Lam, S., Rao, M., Li, H., & Li, X.-J. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.5.1277-1287.2002 · Cited by 340
Transcriptional Specificity of Human SWI/SNF BRG1 and BRM Chromatin Remodeling Complexes
Kadam, S., & Emerson, B. M. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00034-0 · Cited by 338
Sp1: Emerging roles—Beyond constitutive activation of TATA-less housekeeping genes
Wierstra, I. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.03.074 · Cited by 336
Transcription factor Sp1 expression is a significant predictor of survival in human gastric cancer.
Wang, L., Wei, D., Huang, S., Peng, Z., Le, X., Wu, T. T., Yao, J. C., Ajani, J. A., & Xie, K. (2003) · PubMed · Cited by 334
Graff, J. R., Herman, J. G., Myöhänen, S., Baylin, S. B., & Vertino, P. M. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.35.22322 · Cited by 319
The role of Sp1 and Sp3 in normal and cancer cell biology
Li, L., & Davie, J. R. (2010) · Annals of Anatomy - Anatomischer Anzeiger · doi:10.1016/j.aanat.2010.07.010 · Cited by 318
Milanini, J., Viñals, F., Pouysségur, J., & Pagès, G. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.29.18165 · Cited by 315
Evidence for physical interaction between the zinc-finger transcription factors YY1 and Sp1.
Lee, J. S., Galvin, K. M., & Shi, Y. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.13.6145 · Cited by 309
Shi, Q., Le, X., Abbruzzese, J. L., Peng, Z., Qian, C., Tang, H. W., Xiong, Q., Wang, B., Li, X. C., & Xie, K. (2001) · PubMed · Cited by 294
Identification of Two Sp1 Phosphorylation Sites for p42/p44 Mitogen-activated Protein Kinases
Milanini-Mongiat, J., Pouysségur, J., & Pagès, G. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201753200 · Cited by 287
Transcriptional analysis of human survivin gene expression
Li, F., & Altieri, D. C. (1999) · Biochemical Journal · doi:10.1042/0264-6021:3440305 · Cited by 286
Lynch, T. P., Ferrer, C. M., Jackson, S. R., Shahriari, K. S., Vosseller, K., & Reginato, M. J. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.302547 · Cited by 286
Wick, M., Zubov, D., & Hagen, G. (1999) · Gene · doi:10.1016/s0378-1119(99)00108-0 · Cited by 280
Palumbo, S. L., Ebbinghaus, S. W., & Hurley, L. H. (2009) · Journal of the American Chemical Society · doi:10.1021/ja902281d · Cited by 279
O -linkage of N -acetylglucosamine to Sp1 activation domain inhibits its transcriptional capability
Yang, X., Su, K., Roos, M. D., Chang, Q., Paterson, A. J., & Kudlow, J. E. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.111099998 · Cited by 274
Qin, H., Sun, Y., & Benveniste, E. N. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.41.29130 · Cited by 271
Emili, A., Greenblatt, J., & Ingles, C. J. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.3.1582 · Cited by 265
Cell Cycle-Regulated Association of E2F1 and Sp1 Is Related to Their Functional Interaction
Lin, S.-Y., Black, A. R., Kostic, D., Pajovic, S., Hoover, C. N., & Azizkhan, J. C. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.4.1668 · Cited by 261
Methylation of Adjacent CpG Sites Affects Sp1/Sp3 Binding and Activity in the p21Cip1 Promoter
Zhu, W.-G., Srinivasan, K., Dai, Z., Duan, W., Druhan, L. J., Ding, H., Yee, L., Villalona-Calero, M. A., Plass, C., & Otterson, G. A. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.12.4056-4065.2003 · Cited by 257
DNA looping and Sp1 multimer links: a mechanism for transcriptional synergism and enhancement.
Mastrangelo, I. A., Courey, A. J., Wall, J. S., Jackson, S. P., & Hough, P. V. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.13.5670 · Cited by 257
Wei, D., Wang, L., He, Y., Xiong, H. Q., Abbruzzese, J. L., & Xie, K. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-1945 · Cited by 246
Duan, H., Heckman, C. A., & Boxer, L. M. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.5.1608-1619.2005 · Cited by 242
Armstrong, S. A., Barry, D. A., Leggett, R. W., & Mueller, C. R. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.21.13489 · Cited by 231
A non-canonical DNA structure is a binding motif for the transcription factor SP1 in vitro
Raiber, E.-A., Kranaster, R., Lam, E., Nikan, M., & Balasubramanian, S. (2012) · Nucleic Acids Research · doi:10.1093/nar/gkr882 · Cited by 230
Epithelial E- and P-cadherins: Role and clinical significance in cancer
Paredes, J., Figueiredo, J., Albergaria, A., Oliveira, P., Carvalho, J., Ribeiro, A. S., Caldeira, J., Costa, Â. M., Simões-Correia, J., Oliveira, M. J., et al. (2012) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2012.05.002 · Cited by 229
Majello, B., De Luca, P., Hagen, G., Suske, G., & Lania, L. (1994) · Nucleic Acids Research · doi:10.1093/nar/22.23.4914 · Cited by 229
Sp1 Is Involved in Akt-mediated Induction of VEGF Expression through an HIF-1–independent Mechanism
Pore, N., Liu, S., Shu, H.-K., Li, B., Haas-Kogan, D., Stokoe, D., Milanini-Mongiat, J., Pages, G., O'Rourke, D. M., Bernhard, E., et al. (2004) · Molecular Biology of the Cell · doi:10.1091/mbc.e04-05-0374 · Cited by 229
Thiesen, H.-J., & Bach, C. (1990) · Nucleic Acids Research · doi:10.1093/nar/18.11.3203 · Cited by 225
O Glycosylation of an Sp1-Derived Peptide Blocks Known Sp1 Protein Interactions
Roos, M. D., Su, K., Baker, J. R., & Kudlow, J. E. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.11.6472 · Cited by 223
Crossley, M., Whitelaw, E., Perkins, A., Williams, G., Fujiwara, Y., & Orkin, S. H. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.4.1695 · Cited by 222
An inhibitor domain in Sp3 regulates its glutamine-rich activation domains.
Dennig, J., Beato, M., & Suske, G. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00950.x · Cited by 220
Jeang, K. T., Chun, R., Lin, N. H., Gatignol, A., Glabe, C. G., & Fan, H. (1993) · Journal of Virology · doi:10.1128/jvi.67.10.6224-6233.1993 · Cited by 217
Lagger, G., Doetzlhofer, A., Schuettengruber, B., Haidweger, E., Simboeck, E., Tischler, J., Chiocca, S., Suske, G., Rotheneder, H., Wintersberger, E., et al. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.8.2669-2679.2003 · Cited by 216
Kim, S. H., Shanware, N. P., Bowler, M. J., & Tibbetts, R. S. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.154831 · Cited by 214
Biggs, J. R., Kudlow, J. E., & Kraft, A. S. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.2.901 · Cited by 210
Regulatory mechanisms controlling human E-cadherin gene expression
Liu, Y.-N., Lee, W.-W., Wang, C.-Y., Chao, T.-H., Chen, Y., & Chen, J. H. (2005) · Oncogene · doi:10.1038/sj.onc.1208991 · Cited by 209
Li, F., & Altieri, D. C. (1999) · PubMed · Cited by 208
Sp1 binding is inhibited by mCpmCpG methylation
Clark, S. J., Harrison, J., & Molloy, P. L. (1997) · Gene · doi:10.1016/s0378-1119(97)00164-9 · Cited by 207
The VEGF Pathway in Cancer and Disease: Responses, Resistance, and the Path Forward
Kieran, M. W., Kalluri, R., & Cho, Y.-J. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006593 · Cited by 206
Functional Analyses of the Transcription Factor Sp4 Reveal Properties Distinct from Sp1 and Sp3
Hagen, G., Dennig, J., Preiß, A., Beato, M., & Suske, G. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.42.24989 · Cited by 203
Finkenzeller, G., Sparacio, A., Technau, A., Marmé, D., & Siemeister, G. (1997) · Oncogene · doi:10.1038/sj.onc.1201219 · Cited by 201
Kundu, T. K., Palhan, V. B., Wang, Z., An, W., Cole, P. A., & Roeder, R. G. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)00054-x · Cited by 201
Oh, S. T., Kyo, S., & Laimins, L. A. (2001) · Journal of Virology · doi:10.1128/jvi.75.12.5559-5566.2001 · Cited by 201
Dysregulation of p53/Sp1 Control Leads to DNA Methyltransferase-1 Overexpression in Lung Cancer
Lin, R.-K., Wu, C.-Y., Chang, J.-W., Juan, L.-J., Hsu, H.-S., Chen, C.-Y., Lu, Y.-Y., Tang, Y.-A., Yang, Y.-C., Yang, P.-C., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-4161 · Cited by 200
Abdelrahim, M., Smith, R., Burghardt, R., & Safe, S. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0713 · Cited by 199
Yao, J. C., Wang, L., Wei, D., Gong, W., Hassan, M., Wu, T.-T., Mansfield, P., Ajani, J., & Xie, K. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0628 · Cited by 199
Schäfer, G., Cramer, T., Suske, G., Kemmner, W., Wiedenmann, B., & Höcker, M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211999200 · Cited by 198
Haas, T. L., Stitelman, D., Davis, S. J., Apte, S. S., & Madri, J. A. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.32.22679 · Cited by 188
Zinc in innate and adaptive tumor immunity
John, E., Laskow, T. C., Buchser, W. J., Pitt, B. R., Basse, P. H., Butterfield, L. H., Kalinski, P., & Lotze, M. T. (2010) · Journal of Translational Medicine · doi:10.1186/1479-5876-8-118 · Cited by 186
Kardassis, D., Papakosta, P., Pardali, K., & Moustakas, A. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.41.29572 · Cited by 185
Won, J., Yim, J., & Kim, T. K. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m206064200 · Cited by 180
Tatsukawa, H., Fukaya, Y., Frampton, G., Martinez–Fuentes, A., Suzuki, K., Kuo, T., Nagatsuma, K., Shimokado, K., Okuno, M., Wu, J., et al. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.01.007 · Cited by 178
Identification of the DNA sequence that interacts with the gut-enriched Kruppel-like factor
Shields, J. (1998) · Nucleic Acids Research · doi:10.1093/nar/26.3.796 · Cited by 178
Up-regulation of DNA-dependent protein kinase activity and Sp1 in colorectal cancer
Hosoi, Y., Watanabe, T., Nakagawa, K., Matsumoto, Y., Enomoto, A., Morita, A., Nagawa, H., & Suzuki, N. (2004) · International Journal of Oncology · doi:10.3892/ijo.25.2.461 · Cited by 175
Dishonorable Discharge: The Oncogenic Roles of Cleaved E-Cadherin Fragments
David, J. M., & Rajasekaran, A. K. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-3498 · Cited by 174
Growth/Cell Cycle Regulation of Sp1 Phosphorylation
Black, A. R., Jensen, D., Lin, S.-Y., & Azizkhan, J. C. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.3.1207 · Cited by 171
Lee, S.-O., Abdelrahim, M., Yoon, K., Chintharlapalli, S., Papineni, S., Kim, K., Wang, H., & Safe, S. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1992 · Cited by 171
Xiao, H., Hasegawa, T., & Isobe, K.-I. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.2.1371 · Cited by 171
O-GlcNAc modification, insulin signaling and diabetic complications
Issad, T., Masson, E., & Pagesy, P. (2010) · Diabetes & Metabolism · doi:10.1016/j.diabet.2010.09.001 · Cited by 170
Liu, W., Innocenti, F., Wu, M. H., Desai, A. A., Dolan, M. E., Cook, E. H., & Ratain, M. J. (2005) · Cancer Research · doi:10.1158/0008-5472.46.65.1 · Cited by 170
Suzuki, T., Kimura, A., Nagai, R., & Horikoshi, M. (2000) · Genes to Cells · doi:10.1046/j.1365-2443.2000.00302.x · Cited by 166
Apt, D., Watts, R. M., Suske, G., & Bernard, H.-U. (1996) · Virology · doi:10.1006/viro.1996.0530 · Cited by 164
Genome-wide assessment of differential roles for p300 and CBP in transcription regulation
Ramos, Y. F. M., Hestand, M. S., Verlaan, M., Krabbendam, E., Ariyurek, Y., van Galen, M., van Dam, H., van Ommen, G.-J. B., den Dunnen, J. T., Zantema, A., et al. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq184 · Cited by 163
Quercetin augments TRAIL-induced apoptotic death: Involvement of the ERK signal transduction pathway
Kim, Y.-H., Lee, D.-H., Jeong, J.-H., Guo, Z. S., & Lee, Y. J. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2008.02.016 · Cited by 162
Pal, S., Claffey, K. P., Cohen, H. T., & Mukhopadhyay, D. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.41.26277 · Cited by 162
Fli-1 Inhibits Collagen Type I Production in Dermal Fibroblasts via an Sp1-dependent Pathway
Czuwara-Ladykowska, J., Shirasaki, F., Jackers, P., Watson, D. K., & Trojanowska, M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010133200 · Cited by 162
Sp1, a New Biomarker That Identifies a Subset of Aggressive Pancreatic Ductal Adenocarcinoma
Jiang, N. Y., Woda, B. A., Banner, B. F., Whalen, G. F., Dresser, K. A., & Lu, D. (2008) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-07-2791 · Cited by 159
Liu, S.-J., Liu, Z., Xie, Z., Pang, J.-X., Yu, J.-H., Lehmann, E., Huynh, L., Vukosavljevic, T., Mitsui, T., Klisovic, R. B., et al. (2008) · Blood · doi:10.1182/blood-2007-08-110171 · Cited by 159
Ohlsson, C., Kley, N., Werner, H., & LeRoith, D. (1998) · Endocrinology · doi:10.1210/endo.139.3.5832 · Cited by 158
Guan, H., Cai, J., Zhang, N., Wu, J., Yuan, J. X., Li, J., & Li, M. (2011) · International Journal of Cancer · doi:10.1002/ijc.26049 · Cited by 155
Sp1 expression regulates lung tumor progression
Hsu, T.-I., Wang, M.-C., Chen, S. Y., Yeh, Y.-M., Su, W., Chang, W.-C., & Hung, J.-J. (2011) · Oncogene · doi:10.1038/onc.2011.568 · Cited by 152
Modulation of Sp1 Phosphorylation by Human Immunodeficiency Virus Type 1 Tat
Chun, R. F., Semmes, O. J., Neuveut, C., & Jeang, K. (1998) · Journal of Virology · doi:10.1128/jvi.72.4.2615-2629.1998 · Cited by 151
Billon, N., Carlisi, D., Datto, M., van Grunsven, L. A., Watt, A. J., Wang, X., & Rudkin, B. B. (1999) · Oncogene · doi:10.1038/sj.onc.1202712 · Cited by 150
Stoner, M. A., Wormke, M., Saville, B., Samudio, I. J., Qin, C., Abdelrahim, M., & Safe, S. H. (2003) · Oncogene · doi:10.1038/sj.onc.1207201 · Cited by 147
Transcriptional Repression and Heterochromatin Formation by MBD1 and MCAF/AM Family Proteins
Ichimura, T., Watanabe, S., Sakamoto, Y., Aoto, T., Fujita, N., & Nakao, M. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m413654200 · Cited by 146
Kageyama, R., Merlino, G. T., & Pastan, I. H. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)68790-3 · Cited by 142
Structures of Zinc Finger Domains from Transcription Factor Sp1
Narayan, V. A., Kriwacki, R. W., & Caradonna, J. P. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.12.7801 · Cited by 139
Zannetti, A., Vecchio, S. D., Carriero, M. V., Fonti, R., Franco, P., Botti, G., D’Aiuto, G., Stoppelli, M. P., & Salvatore, M. (2000) · PubMed · Cited by 137
Saluja, D., Vassallo, M. F., & Tanese, N. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.10.5734 · Cited by 133
Kriwacki, R. W., Schultz, S. C., Steitz, T. A., & Caradonna, J. P. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.20.9759 · Cited by 132
Strunnikova, M., Schagdarsurengin, U., Kehlen, A., Garbe, J. C., Stampfer, M. R., & Dammann, R. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.10.3923-3933.2005 · Cited by 131
Hung, J., Wang, Y.-T., & Chang, W. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.5.1770-1785.2006 · Cited by 130
Tanese, N., Saluja, D., Vassallo, M. F., Chen, J., & Admon, A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.24.13611 · Cited by 129
CHIEFARI, E. D., Brunetti, A., Arturi, F., Bidart, J., Russo, D., Schlumberger, M. J., & Filetti, S. (2002) · BMC Cancer · doi:10.1186/1471-2407-2-35 · Cited by 128
Liu, C., Fang, X., Ge, Z., Jalink, M., Kyo, S., Björkholm, M., Gruber, A., Sjöberg, J., & Xu, D. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4126 · Cited by 128
Pathi, S., Jutooru, I., Chadalapaka, G., Nair, V., Lee, S.-O., & Safe, S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0048208 · Cited by 127
Abdelrahim, M., & Safe, S. H. (2005) · Molecular Pharmacology · doi:10.1124/mol.105.011825 · Cited by 127
Hou, M., Wang, X., Popov, N., Zhang, A., Zhao, X., Zhou, R., Zetterberg, A., Björkholm, M., Arsenian‐Henriksson, M., Gruber, A., et al. (2002) · Experimental Cell Research · doi:10.1006/excr.2001.5462 · Cited by 125
Johnson, A., Ishii, S., Jinno, Y., Pastan, I. H., & Merlino, G. T. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)60621-0 · Cited by 124
Promoter structure and transcription initiation sites of the human death receptor 5/TRAIL‐R2 gene 1
Yoshida, T., Maeda, A., Tani, N., & Sakai, T. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)02947-7 · Cited by 124
Matsumoto, N., Laub, F., Aldabe, R., Zhang, W., Ramirez, F., Yoshida, T., & Terada, M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.43.28229 · Cited by 124
Carneiro, P., Fernandes, M. S., Figueiredo, J., Caldeira, J., Carvalho, J., Pinheiro, H. C., Leite, M., Melo, S., Oliveira, P., Simões‐Correia, J., et al. (2012) · FEBS Letters · doi:10.1016/j.febslet.2012.07.045 · Cited by 123
Yu, D. C. W., Waby, J. S., Chirakkal, H., Staton, C. A., & Corfe, B. M. (2010) · Molecular Cancer · doi:10.1186/1476-4598-9-276 · Cited by 121
Haley, J. D., Whittle, N., Bennet, P., Kinchington, D., Ullrich, A., & Waterfield, M. D. (1987) · PubMed · Cited by 120
Maor, S., Mayer, D., Yarden, R. I., et al. (2006) · Journal of Endocrinology · doi:10.1677/joe.1.07016 · Cited by 119
Knappskog, S., Bjørnslett, M., Myklebust, L. M., Huijts, P. E. A., Vreeswijk, M. P. G., Edvardsen, H., Guo, Y., Zhang, X., Yang, M., Ylisaukko‐oja, S. K., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2010.12.019 · Cited by 118
Banine, F., Bartlett, C. S., Gunawardena, R. W., Muchardt, C., Yaniv, M., Knudsen, E. S., Weissman, B. E., & Sherman, L. S. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3554 · Cited by 118
Wei, Z., Jiang, X. L., Qiao, H., Zhai, B., Zhang, L., Zhang, Q., Wu, Y., Jiang, H., & Sun, X. (2013) · Cellular Signalling · doi:10.1016/j.cellsig.2013.01.011 · Cited by 117
Cyclin A–CDK phosphorylates Sp1 and enhances Sp1‐mediated transcription
Borja, P. F. D., Collins, N. K., Du, P., Azizkhan‐Clifford, J., & Mudryj, M. M. (2001) · The EMBO Journal · doi:10.1093/emboj/20.20.5737 · Cited by 117
Self-citationNam, E.-H., Lee, Y., Park, Y., Lee, S. E., & Kim, S. (2012) · Carcinogenesis · doi:10.1093/carcin/bgs005 · Cited by 116
Kazi, A. A., Jones, J. M., & Koos, R. D. (2005) · Molecular Endocrinology · doi:10.1210/me.2004-0388 · Cited by 115
Waby, J. S., Chirakkal, H., Yu, D. C. W., Griffiths, G. J., Benson, R., Bingle, C. D., & Corfe, B. M. (2010) · Molecular Cancer · doi:10.1186/1476-4598-9-275 · Cited by 115
Chuang, J., Wang, Y.-T., Yeh, S.-H., Liu, Y., Chang, W., & Hung, J. (2008) · Molecular Biology of the Cell · doi:10.1091/mbc.e07-09-0881 · Cited by 115
Hao, B., Miao, X., LI, Y., Zhang, X., Sun, T., Liang, G., Zhao, Y., Zhou, Y., Wang, H., Chen, X., et al. (2006) · Oncogene · doi:10.1038/sj.onc.1209355 · Cited by 114
Ulrich, C. M., Whitton, J. A., Yu, J., Sibert, J. G., Sparks, R., Potter, J. D., & Bigler, J. (2005) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-04-0510 · Cited by 114
Impaired ossification in mice lacking the transcription factor Sp3
Göllner, H., Dani, C., Phillips, B. W., Philipsen, S., & Suske, G. (2001) · Mechanisms of Development · doi:10.1016/s0925-4773(01)00420-8 · Cited by 113
Liu, H. S., Kang, H., Liu, R., Chen, X., & Zhao, K. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.18.6471-6479.2002 · Cited by 113
Zhang, Y., & Dufau, M. L. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m204417200 · Cited by 112
Reisinger, K., Kaufmann, R., & Gille, J. (2002) · Journal of Cell Science · doi:10.1242/jcs.00237 · Cited by 111
Involvement of the Sp1 Site in ras-Mediated Downregulation of the RECK Metastasis Suppressor Gene
Sasahara, R. M., Takahashi, C., & Noda, M. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.1552 · Cited by 111
Estève, P., Chin, H. G., & Pradhan, S. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m606203200 · Cited by 111
Benasciutti, E., Pagès, G., Kenzior, O., Folk, W. R., Blasi, F., & Crippa, M. P. (2004) · Blood · doi:10.1182/blood-2003-08-2661 · Cited by 111
Skp2 overexpression increases the expression of MMP-2 and MMP-9 and invasion of lung cancer cells
Hung, W., Tseng, W., Shiea, J., & Chang, H. (2009) · Cancer Letters · doi:10.1016/j.canlet.2009.06.032 · Cited by 110
Interaction between the two ubiquitously expressed transcription factors NF-Y and Sp1
Roder, K., Wolf, S. S., Larkin, K., & Schweizer, M. (1999) · Gene · doi:10.1016/s0378-1119(99)00180-8 · Cited by 109
Hsu, M., Chang, H., & Hung, W. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m510937200 · Cited by 109
Yuan, H., Gong, A., & Young, C. Y. F. (2005) · Carcinogenesis · doi:10.1093/carcin/bgi021 · Cited by 109
An N-terminal Region of Sp1 Targets Its Proteasome-dependent Degradation in Vitro
Su, K., Roos, M. D., Yang, X., Han, I., Paterson, A. J., & Kudlow, J. E. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.21.15194 · Cited by 105
Pan, M., & Hung, W.-C. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202334200 · Cited by 103
Knight, J. S., Cotter, M. A., & Robertson, E. S. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101890200 · Cited by 103
Lee, K., Chae, J., & Shim, J. (2012) · Journal of Biomedical Science · doi:10.1186/1423-0127-19-60 · Cited by 100
Kim, J. Y., Kim, E. H., Park, S. S., Lim, J. H., Kwon, T. K., & Choi, K. S. (2008) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21958 · Cited by 100
Yun, S. S., Dardik, A., Haga, M., Yamashita, A., Yamaguchi, S., Koh, Y.-B., Madri, J. A., & Sumpio, B. E. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m205417200 · Cited by 96
Majumdar, G., Harrington, A., Hungerford, J., Martinez-Hernandez, A., Gerling, I., Raghow, R., & Solomon, S. S. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m511223200 · Cited by 94
Endoh, T., Tsuji, N., Asanuma, K., Yagihashi, A., & Watanabe, N. (2005) · Experimental Cell Research · doi:10.1016/j.yexcr.2004.12.014 · Cited by 94
Defective death receptor signaling as a cause of tumor immune escape
French, L. E., & Tschopp, J. (2002) · Seminars in Cancer Biology · doi:10.1006/scbi.2001.0405 · Cited by 93
Sp1 and Sp3 regulate basal transcription of the survivin gene
Xu, R., Zhang, P., Huang, J. J., Ge, S., Lu, J., & Qian, G. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.02.140 · Cited by 93
Suzuki, A., Sanda, N., Miyawaki, Y., Fujimori, Y., Yamada, T., Takagi, A., Murate, T., Saito, H., & Kojima, T. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.062430 · Cited by 93
BRCA1–Sp1 interactions in transcriptional regulation of the IGF‐IR gene
Abramovitch, S., Glaser, T., Ouchi, T., & Werner, H. (2003) · FEBS Letters · doi:10.1016/s0014-5793(03)00315-6 · Cited by 93
Eisermann, K., Broderick, C. J., Bazarov, A., Moazam, M., & Fraizer, G. C. (2013) · Molecular Cancer · doi:10.1186/1476-4598-12-7 · Cited by 93
Estrogen Regulates KiSS1 Gene Expression through Estrogen Receptor α and SP Protein Complexes
Li, D., Mitchell, D., Luo, J., Yi, Z., Cho, S.-G., Guo, J., Li, X., Ning, G., Wu, X., & Liu, M. (2007) · Endocrinology · doi:10.1210/en.2007-0154 · Cited by 90
Sp1-Mediated Transcription of the Werner Helicase Gene Is Modulated by Rb and p53
Yamabe, Y., Shimamoto, A., Goto, M., Yokota, J., Sugawara, M., & Furuichi, Y. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.11.6191 · Cited by 90
Phosphorylation of Sp1 in Response to DNA Damage by Ataxia Telangiectasia-Mutated Kinase
Olofsson, B. A., Kelly, C. M., Kim, J., Hornsby, S. M., & Azizkhan‐Clifford, J. (2007) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-07-0374 · Cited by 90
Self-citationThe Transcriptional Repressor Sp3 Is Associated with CK2-phosphorylated Histone Deacetylase 2
Sun, J.-M., Chen, H. Y., Moniwa, M., Litchfield, D. W., Seto, E., & Davie, J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.c200378200 · Cited by 89
Donovan, K., Alekseev, O., Qi, X., Cho, W., & Azizkhan‐Clifford, J. (2014) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.14-14048 · Cited by 89
Self-citationAthanikar, J. N., Sanchez, H. B., & Osborne, T. F. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.9.5193 · Cited by 88
Yieh, L., Sanchez, H. B., & Osborne, T. F. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.13.6102 · Cited by 87
Dong, J., Tsai‐Morris, C., & Dufau, M. L. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m512826200 · Cited by 87
Curtin, D., Jenkins, S. C., Farmer, N., Anderson, A. C., Haisenleder, D. J., Rissman, E. F., Wilson, E. M., & Shupnik, M. A. (2001) · Molecular Endocrinology · doi:10.1210/mend.15.11.0723 · Cited by 86
Maor, S., Yosepovich, A., Papa, M. Z., Yarden, R. I., Mayer, D., Friedman, E., & Werner, H. (2007) · Cancer Letters · doi:10.1016/j.canlet.2007.07.019 · Cited by 85
Src oncogene activates MMP‐2 expression via the ERK/Sp1 pathway
Kuo, L., Chang, H., Leu, T., Maa, M., & Hung, W. (2006) · Journal of Cellular Physiology · doi:10.1002/jcp.20616 · Cited by 85
Regulation of Sp1 by cell cycle related proteins
Tapias, A., Ciudad, C. J., Roninson, I. B., & Noé, V. (2008) · Cell Cycle · doi:10.4161/cc.7.18.6671 · Cited by 84
Cited by
Akt in cancer: Mediator and more
Revathidevi, S., & Munirajan, A. K. (2019) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.06.002 · Cited by 691
Sp1 transcription factor: A long-standing target in cancer chemotherapy
Vizcaíno, C., Mansilla, S., & Portugal, J. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2015.05.008 · Cited by 377
Signaling pathways in cancer metabolism: mechanisms and therapeutic targets
You, M., Xie, Z., Zhang, N., Zhang, Y., Xiao, D., Liu, S., Zhuang, W., Li, L., & Tao, Y. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01442-3 · Cited by 292
Gallagher, E. J., & LeRoith, D. (2020) · Nature Reviews Cancer · doi:10.1038/s41568-020-0295-5 · Cited by 241
Anjali, G., Kaur, S., Lakra, R., Taneja, J., Kalsey, G. S., Nagendra, A., Shrivastav, T. G., Gouri Devi, M., Malhotra, N., Kriplani, A., et al. (2015) · Cellular Signalling · doi:10.1016/j.cellsig.2015.09.011 · Cited by 42
Metadata
- Authors
- Beishline, K., & Azizkhan‐Clifford, J.
- Venue
- The FEBS Journal
- Publisher
- Wiley
- Published
- 2015-01
- Volume
- 282
- Issue
- 2
- Pages
- 224-258
- ISSN
- 1742-464X (ISSN-L)
- 1742-4658
- OpenAlex
- W2019732936
- Cited by
- 524
- References
- 341
- FWCI
- 11.80
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.